All In Biotech

Drug Trial Radar · NCT04278404

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs

Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

5,000

Planned (sponsor's estimate)

Start

Mar 5, 2020

Primary completion

Nov 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Duke UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The Emmes Company, LLC; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First posted
Feb 20, 2020

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 0 years, up to 20 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.

Conditions

  • Coronavirus Infection (COVID-19)
  • Pulmonary Arterial Hypertension
  • Urinary Tract Infections in Children
  • Hypertension
  • Pain
  • Hyperphosphatemia
  • Primary Hyperaldosteronism
  • Edema
  • Hypokalemia
  • Heart Failure
  • Hemophilia
  • Menorrhagia
  • Insomnia
  • Pneumonia
  • Skin Infection
  • Arrythmia
  • Asthma in Children
  • Bronchopulmonary Dysplasia
  • Adrenal Insufficiency
  • Fibrinolysis; Hemorrhage
  • Attention Deficit Hyperactivity Disorder
  • Multisystem Inflammatory Syndrome in Children (MIS-C)
  • Kawasaki Disease
  • Coagulation Disorder
  • Down Syndrome

Interventions

  • The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:Drug

    The prescribing of drugs to children is not part of this protocol. Participants will receive DOIs as prescribed by their treating provider.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clearance (CL) or apparent oral clearance (CL/F) as measured by PK samplingTime frame: Data will be collected up to 90 days from the time of consent. For participants with Down Syndrome enrolling at sites designated as Down Syndrome sites, participants will be in the study for up to 210 days.
  2. Volume of distribution (V) or apparent oral volume of distribution (V/F) as measured by PK samplingTime frame: Data will be collected up to 90 days from the time of consent. For participants with Down Syndrome enrolling at sites designated as Down Syndrome sites, participants will be in the study for up to 210 days.
  3. Elimination rate constant (ke) as measured by PK samplingTime frame: Data will be collected up to 90 days from the time of consent. For participants with Down Syndrome enrolling at sites designated as Down Syndrome sites, participants will be in the study for up to 210 days.
  4. Half-life (t1/2) as measured by PK samplingTime frame: Data will be collected up to 90 days from the time of consent. For participants with Down Syndrome enrolling at sites designated as Down Syndrome sites, participants will be in the study for up to 210 days.
  5. Absorption rate constant (ka) as measured by PK samplingTime frame: Data will be collected up to 90 days from the time of consent. For participants with Down Syndrome enrolling at sites designated as Down Syndrome sites, participants will be in the study for up to 210 days.
  6. AUC (area under the curve) as measured by PK samplingTime frame: Data will be collected up to 90 days from the time of consent. For participants with Down Syndrome enrolling at sites designated as Down Syndrome sites, participants will be in the study for up to 210 days.
  7. Maximum concentration (Cmax) as measured by PK samplingTime frame: Data will be collected up to 90 days from the time of consent. For participants with Down Syndrome enrolling at sites designated as Down Syndrome sites, participants will be in the study for up to 210 days.
  8. Time to achieve maximum concentration (Tmax) as measured by PK samplingTime frame: Data will be collected up to 90 days from the time of consent. For participants with Down Syndrome enrolling at sites designated as Down Syndrome sites, participants will be in the study for up to 210 days.

Locations

52 sites in 2 countries. Site status is shown where the registry gives one.

  • Phoenix Children's Hospital

    Phoenix, Arizona · Completed

  • Arkansas Children's Hospital Research Institute

    Little Rock, Arkansas · Completed

  • University of California, Los Angeles Medical Center

    Los Angeles, California · Completed

  • Lucile Packard Children's Hospital

    Palo Alto, California · Recruiting

  • Colorado University Denver

    Aurora, Colorado · Completed

  • The Children's Hospital Colorado

    Aurora, Colorado · Completed

  • Alfred I. DuPont Hospital for Children

    Wilmington, Delaware · Completed

  • University of Florida Jacksonville Shands Medical Center

    Jacksonville, Florida · Completed

  • Kapiolani Womens and Childrens Medical Center

    Honolulu, Hawaii · Completed

  • Ann and Robert H. Lurie Childrens Hospital of Chicago

    Chicago, Illinois · Completed

  • Ann and Robert H. Lurie Childrens Hospital of Chicago

    Chicago, Illinois · Completed

  • Riley Hospital for Children at Indiana University

    Indianapolis, Indiana · Completed

  • University of Iowa Stead Family Children's Hospital

    Iowa City, Iowa · Completed

  • University of Kansas Medical Center-JG Kidney Institute

    Kansas City, Kansas · Completed

  • University of Louisville Norton Childrens Hospital

    Louisville, Kentucky · Completed

  • Tulane University Health Science Center

    New Orleans, Louisiana · Completed

  • Ochsner Baptist Clinical Trials Unit

    New Orleans, Louisiana · Completed

  • University of Maryland Medical Center

    Baltimore, Maryland · Completed

  • Boston Children's Hospital

    Boston, Massachusetts · Completed

  • Massachusetts General Hospital

    Lexington, Massachusetts · Completed

  • University of Minnesota

    Minneapolis, Minnesota · Completed

  • University of Mississippi Medical Center

    Jackson, Mississippi · Completed

  • Mississippi Center for Advanced Medicine

    Madison, Mississippi · Completed

  • Children's Mercy Hospital

    Kansas City, Missouri · Completed

  • University of Nebraska Medical Center

    Omaha, Nebraska · Completed

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire · Completed

  • University of New Mexico Health Science Center

    Albuquerque, New Mexico · Completed

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina · Completed

  • Duke University Health System

    Durham, North Carolina · Recruiting

  • Cincinnati Childrens Hospital Medical Center

    Cincinnati, Ohio · Completed

  • Cincinnati Childrens Hospital Medical Center

    Cincinnati, Ohio · Recruiting

  • Board of Regents of the University of Oklahoma

    Oklahoma City, Oklahoma · Completed

  • Oregon Health and Science University

    Portland, Oregon · Completed

  • Pennsylvania State University--Hershey Children's Hospital

    Hershey, Pennsylvania · Completed

  • Rhode Island Hospital

    Providence, Rhode Island · Completed

  • Medical University of South Carolina Children's Hospital

    Charleston, South Carolina · Completed

  • University of South Carolina

    Columbia, South Carolina · Completed

  • Avera McKennan Hospital & University Medical Center

    Sioux Falls, South Dakota · Completed

  • Monroe Carell Jr. Children's Hospital at Vanderbilt

    Nashville, Tennessee · Completed

  • Dell Children's Medical Center of Central Texas

    Austin, Texas · Recruiting

Showing 40 of 52 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.